Funder
the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference33 articles.
1. [1] Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. 2020. Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis. Front Oncol 10:171
2. [2] Cervello M, Emma MR, Augello G, Cusimano A, Giannitrapani L, Soresi M, et al. 2020. New landscapes and horizons in hepatocellular carcinoma therapy. Aging (Albany NY) 12:3053-94
3. [3] Gang G, Yu HK, Xu Z. 2015. Sorafenib combined with radiofrequency ablation in the treatment of a patient with renal cell carcinoma plus primary hepatocellular carcinoma. J Cancer Res Ther 11:1026
4. [4] Liu C, Chen Z, Chen Y, Lu J, Li Y, Wang S, et al. 2016. Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms. Mol Pharm 13:599-608
5. [5] Sugimoto K, Moriyasu F, Saito K, Rognin N, Kamiyama N, Furuichi Y, et al. 2013. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US. Liver Int 33:605-15
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献